loading
前日終値:
$3.42
開ける:
$3.43
24時間の取引高:
2.00M
Relative Volume:
1.39
時価総額:
$546.74M
収益:
$288.95M
当期純損益:
$-119.03M
株価収益率:
-4.1645
EPS:
-0.9005
ネットキャッシュフロー:
$60.67M
1週間 パフォーマンス:
+3.43%
1か月 パフォーマンス:
+11.72%
6か月 パフォーマンス:
+67.33%
1年 パフォーマンス:
-24.09%
1日の値動き範囲:
Value
$3.37
$3.80
1週間の範囲:
Value
$3.30
$3.80
52週間の値動き範囲:
Value
$1.665
$6.21

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
名前
Maravai Lifesciences Holdings Inc
Name
セクター
Healthcare (1139)
Name
電話
(858) 546-0004
Name
住所
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
職員
550
Name
Twitter
Name
次回の収益日
2025-03-18
Name
最新のSEC提出書
Name
MRVI's Discussions on Twitter

MRVI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
3.77 495.98M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
435.01 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
761.11 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.15 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
921.89 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
200.22 42.58B 447.02M -1.18B -906.14M -6.1812

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2024-12-19 開始されました Guggenheim Neutral
2024-12-05 ダウングレード Goldman Neutral → Sell
2024-11-14 開始されました Wolfe Research Peer Perform
2024-11-08 ダウングレード William Blair Outperform → Mkt Perform
2024-08-28 開始されました Wells Fargo Overweight
2024-08-13 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-04-10 開始されました Craig Hallum Buy
2023-12-12 アップグレード BofA Securities Neutral → Buy
2023-08-08 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2023-05-23 ダウングレード Credit Suisse Outperform → Neutral
2023-05-09 ダウングレード Goldman Buy → Neutral
2023-01-05 ダウングレード UBS Buy → Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-12-07 開始されました RBC Capital Mkts Outperform
2022-11-03 ダウングレード BofA Securities Buy → Neutral
2022-08-25 開始されました Credit Suisse Outperform
2021-08-05 再開されました Credit Suisse Outperform
2020-12-16 開始されました KeyBanc Capital Markets Overweight
2020-12-15 開始されました BofA Securities Buy
2020-12-15 開始されました Credit Suisse Outperform
2020-12-15 開始されました Goldman Buy
2020-12-15 開始されました Jefferies Buy
2020-12-15 開始されました Robert W. Baird Outperform
2020-12-15 開始されました Stifel Buy
2020-12-15 開始されました William Blair Outperform
2020-12-14 開始されました UBS Buy
すべてを表示

Maravai Lifesciences Holdings Inc (MRVI) 最新ニュース

pulisher
07:44 AM

Is Maravai LifeSciences Holdings Inc. (MAR) stock undervalued at current priceMarket Weekly Review & AI Driven Price Predictions - newser.com

07:44 AM
pulisher
06:22 AM

Published on: 2025-11-21 05:22:01 - newser.com

06:22 AM
pulisher
05:39 AM

Will Maravai LifeSciences Holdings Inc. stock outperform value stocksQuarterly Market Review & Accurate Buy Signal Notifications - newser.com

05:39 AM
pulisher
Nov 20, 2025

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 20, 2025
pulisher
Nov 20, 2025

Is Maravai LifeSciences Holdings Inc. stock a top pick in earnings seasonJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Maravai LifeSciences Holdings Inc. (MAR) stock a good hedge against inflationEarnings Recap Report & Daily Growth Stock Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Maravai LifeSciences Holdings Inc. (MAR) stock is a must watch tickerPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How forex fluctuations impact Maravai LifeSciences Holdings Inc. (MAR) stockJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Maravai LifeSciences Holdings Inc. (MAR) stock suitable for passive index fundsSell Signal & AI Enhanced Trading Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 14:21:53 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Maravai LifeSciences Holdings Inc. stock appeals to dividend seekersTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Maravai LifeSciences Holdings Inc. (MAR) stock benefit from infrastructure bill2025 Trade Ideas & Weekly Momentum Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Maravai Lifesciences at Jefferies: Strategic Restructuring Focus By Investing.com - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

Is Maravai LifeSciences Holdings Inc. stock a bargain at current levelsWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Market Risk Report & Reliable Price Breakout Signals - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Maravai LifeSciences Holdings, Inc. (MRVI.MX) Company Profile & Facts - Yahoo! Finance Canada

Nov 18, 2025
pulisher
Nov 18, 2025

Why Maravai LifeSciences Holdings Inc. stock remains on watchlistsJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity - Stock Titan

Nov 18, 2025
pulisher
Nov 18, 2025

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 18, 2025
pulisher
Nov 17, 2025

Maravai Lifesciences CEO Increases Stake with Significant Share Purchase (MRVI) - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

Maravai Lifesciences Holdings Insider Bought Shares Worth $702,689, According to a Recent SEC Filing - MarketScreener

Nov 17, 2025
pulisher
Nov 17, 2025

How Analyst Views on Maravai LifeSciences Are Shifting as the Story Evolves - Yahoo Finance

Nov 17, 2025
pulisher
Nov 16, 2025

Goldman Sachs Downgrades Maravai LifeSciences Holdings (MRVI) - MSN

Nov 16, 2025
pulisher
Nov 16, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Nov 16, 2025
pulisher
Nov 16, 2025

Will Maravai LifeSciences Holdings Inc. stock reach all time highs in 2025Share Buyback & Real-Time Volume Spike Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Why Maravai LifeSciences Holdings Inc. stock remains resilientJuly 2025 Market Mood & Risk Managed Investment Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

What technical signals suggest for Maravai LifeSciences Holdings Inc. stock2025 Top Gainers & Daily Price Action Insights - newser.com

Nov 15, 2025

Maravai Lifesciences Holdings Inc (MRVI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Maravai Lifesciences Holdings Inc (MRVI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Brust Bernd
Chief Executive Officer
Nov 11 '25
Buy
3.24
157,201
509,331
157,201
Brust Bernd
Chief Executive Officer
Nov 12 '25
Buy
3.21
93,358
299,679
250,559
ORESHACK KURT
General Counsel
Jan 31 '25
Sale
5.03
25,000
125,750
167,618
$39.04
price up icon 1.64%
$30.68
price up icon 2.13%
$102.37
price up icon 0.68%
$96.31
price down icon 0.70%
biotechnology ONC
$347.71
price down icon 0.53%
$200.38
price up icon 0.08%
大文字化:     |  ボリューム (24 時間):